GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series
Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and dual glucose insulinotropic polypeptide (GIP)/GLP-1 RA are widely prescribed, but their effectiveness in different subtypes of maturity-onset diabetes of the young (MODY) is unknown.Research design and methods We present a descrip...
שמור ב:
| Principais autores: | , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
2025-04-01
|
| סדרה: | BMJ Open Diabetes Research & Care |
| גישה מקוונת: | https://drc.bmj.com/content/13/2/e004885.full |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
